|
Synonyms: XmAb5871
Compound class:
Antibody
Comment: Obexelimab (XmAb5871) is an anti-CD19 monoclonal antibody [3-4].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
| References |
|
1. Akiyama M, Takeuchi T. (2018)
IgG4-Related Disease: Beyond Glucocorticoids. Drugs Aging, 35 (4): 275-287. [PMID:29546609] |
|
2. Chu SY, Vostiar I, Karki S, Moore GL, Lazar GA, Pong E, Joyce PF, Szymkowski DE, Desjarlais JR. (2008)
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies. Mol Immunol, 45 (15): 3926-33. [PMID:18691763] |
|
3. Horton HM, Chu SY, Ortiz EC, Pong E, Cemerski S, Leung IW, Jacob N, Zalevsky J, Desjarlais JR, Stohl W et al.. (2011)
Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus. J Immunol, 186 (7): 4223-33. [PMID:21357255] |
|
4. Szili D, Cserhalmi M, Bankó Z, Nagy G, Szymkowski DE, Sármay G. (2014)
Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19. MAbs, 6 (4): 991-9. [PMID:24828435] |